BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35679026)

  • 1. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema.
    Montagna G; Zhang J; Sevilimedu V; Charyn J; Abbate K; Gomez EA; Mehrara B; Morrow M; Barrio AV
    JAMA Oncol; 2022 Aug; 8(8):1195-1200. PubMed ID: 35679026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.
    Jia M; Pan L; Yang H; Gao J; Guo F
    Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life After Axillary Lymph Node Dissection Among Racial and Ethnic Minority Women.
    Heller DR; Axelrod B; Sevilimedu V; Morrow M; Mehrara BJ; Barrio AV
    JAMA Surg; 2024 Mar; ():. PubMed ID: 38536186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and Clinical Utility of Prediction Models for Breast Cancer-Related Lymphedema Incorporating Racial Differences in Disease Incidence.
    Rochlin DH; Barrio AV; McLaughlin S; Van Zee KJ; Woods JF; Dayan JH; Coriddi MR; McGrath LA; Bloomfield EA; Boe L; Mehrara BJ
    JAMA Surg; 2023 Sep; 158(9):954-964. PubMed ID: 37436762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
    Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
    J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
    Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
    Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
    Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
    Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
    JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer.
    Black DM; Jiang J; Kuerer HM; Buchholz TA; Smith BD
    JAMA Surg; 2014 Aug; 149(8):788-96. PubMed ID: 25073831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical Lymphedema After Treatment for Breast Cancer: Risk of Progression and Considerations for Early Intervention.
    Bucci LK; Brunelle CL; Bernstein MC; Shui AM; Gillespie TC; Roberts SA; Naoum GE; Taghian AG
    Ann Surg Oncol; 2021 Dec; 28(13):8624-8633. PubMed ID: 34117574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event.
    Barrio AV; Montagna G; Mamtani A; Sevilimedu V; Edelweiss M; Capko D; Cody HS; El-Tamer M; Gemignani ML; Heerdt A; Kirstein L; Moo TA; Pilewskie M; Plitas G; Sacchini V; Sclafani L; Tadros A; Van Zee KJ; Morrow M
    JAMA Oncol; 2021 Dec; 7(12):1851-1855. PubMed ID: 34617979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
    McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
    J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis.
    Lin Y; Xu Y; Wang C; Song Y; Huang X; Zhang X; Cao X; Sun Q
    Breast Cancer; 2021 Nov; 28(6):1261-1272. PubMed ID: 34106427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Kaufman DI; Shah C; Vicini FA; Rizzi M
    Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
    Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
    World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
    Helyer LK; Varnic M; Le LW; Leong W; McCready D
    Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of upper extremity lymphedema after sentinel lymph node biopsy and axillary lymph node dissection: patient-reported outcomes in 3044 patients.
    Poulsen L; Kaur M; Jacobsen AL; Bjarnesen MP; Bjarnesen AP; Klassen AF; Pusic AL; de Vries CEE; Sørensen JA
    Breast Cancer Res Treat; 2022 Jan; 191(1):87-96. PubMed ID: 34643834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary treatment for operable primary breast cancer.
    Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.
    Wijaya WA; Peng J; He Y; Chen J; Cen Y
    Breast; 2020 Oct; 53():189-200. PubMed ID: 32858404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.